|
Sign In to gain access to subscriptions and/or personal tools.
|
Mutans Streptococci Dose Response to Xylitol Chewing Gum
P. Milgrom1,*,
K.A. Ly1,
M.C. Roberts1,2,
M. Rothen3,
G. Mueller3 and
D.K. Yamaguchi1
1 Department of Dental Public Health Sciences, Northwest/Alaska Center to Reduce Oral Health Disparities, Box 357475, University of Washington, Seattle, WA 98195 USA;
2 Department of Pathobiology, University of Washington, Seattle; and
3 Regional Clinical Dental Research Center, University of Washington, Seattle
Correspondence: * corresponding author, dfrc{at}u.washington.edu
Xylitol is promoted in caries-preventive strategies, yet its effective dose range is unclear. This study determined the dose-response of mutans streptococci in plaque and unstimulated saliva to xylitol gum. Participants (n = 132) were randomized: controls (G1) (sorbitol/maltitol), or combinations giving xylitol 3.44 g/day (G2), 6.88 g/day (G3), or 10.32 g/day (G4). Groups chewed 3 pellets/4 times/d. Samples were taken at baseline, 5 wks, and 6 mos, and were cultured on modified Mitis Salivarius agar for mutans streptococci and on blood agar for total culturable flora. At 5 wks, mutans streptococci levels in plaque were 10x lower than baseline in G3 and G4 (P = 0.007/0.003). There were no differences in saliva. At 6 mos, mutans streptococci in plaque for G3 and G4 remained 10x lower than baseline (P = 0.007/0.04). Saliva for G3 and G4 was lower than baseline by 8 to 9x (P = 0.011/0.038). Xylitol at 6.44 g/day and 10.32 g/day reduces mutans streptococci in plaque at 5 wks, and in plaque and unstimulated saliva at 6 mos. A plateau effect is suggested between 6.44 g and 10.32 g xylitol/day.
Key Words: dental plaque mutans streptococci xylitol clinical trials
Journal of Dental Research, Vol. 85, No. 2,
177-181 (2006)
DOI: 10.1177/154405910608500212

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Milgrom, K.A. Ly, and M. Rothen
Xylitol and Its Vehicles for Public Health Needs
Advances in Dental Research,
August 1, 2009;
21(1):
44 - 47.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Twetman
Current Controversies -- Is There Merit?
Advances in Dental Research,
August 1, 2009;
21(1):
48 - 52.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.M. Soderling
Xylitol, Mutans Streptococci, and Dental Plaque
Advances in Dental Research,
August 1, 2009;
21(1):
74 - 78.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Milgrom, K. A. Ly, O. K. Tut, L. Mancl, M. C. Roberts, K. Briand, and M. J. Gancio
Xylitol Pediatric Topical Oral Syrup to Prevent Dental Caries: A Double-blind Randomized Clinical Trial of Efficacy
Arch Pediatr Adolesc Med,
July 1, 2009;
163(7):
601 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Ly, P. Milgrom, and M. Rothen
The Potential of Dental-Protective Chewing Gum in Oral Health Interventions
J Am Dent Assoc,
May 1, 2008;
139(5):
553 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. DePaola, F. A. Curro, and D. T. Zero
Saliva: The precious body fluid
J Am Dent Assoc,
May 1, 2008;
139(suppl_2):
5S - 10S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Zero
Are sugar substitutes also anticariogenic?
J Am Dent Assoc,
May 1, 2008;
139(suppl_2):
9S - 10S.
[Full Text]
[PDF]
|
 |
|
|
|